{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:44:39Z","timestamp":1793378679964,"version":"4.5.0"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Conventional type 1 dendritic cells (cDC1) and conventional type 2 dendritic cells (cDC2) have attracted increasing attention as alternatives to monocyte-derived dendritic cells (moDCs) in cancer immunotherapy. Use of cDCs for therapy has been hindered by their low numbers in peripheral blood. In the present study, we found that extensive spontaneous apoptosis and cDC death in culture within 24hrs represent an additional challenge. Different media conditions that maintain cDC viability and function were investigated. CD141+ cDC1 and CD1c+ cDC2 were isolated from healthy blood donor buffy coats. Low viabilities were found with CellGenix DC, RPMI-1640, and X-VIVO 15 standard culture media and with several supplements at 24hrs and 48hrs. Among multiple factors it was found that GM-CSF improved both cDC1 and cDC2 viability, whereas Flt3-L and IL-4 only increased viability of cDC1 and cDC2, respectively. Combinations of these three cytokines improved viability of both cDCs further, both at 24hrs and 48hrs time points. Although these cytokines have been extensively investigated for their role in myeloid cell differentiation, and are also used clinically, their effects on mature cDCs remain incompletely known, in particular effects on pro-inflammatory or tolerogenic cDC features. HLA-DR, CD80, CD83, CD86, PD-L1 and PD-L2 cDC membrane expressions were relatively little affected by GM-CSF, IL-4 and Flt3-L cytokine supplements compared to the strong induction following Toll-like receptor (TLR) stimulation for 24hrs. With minor exceptions the three cytokines appeared to be permissive to the TLR-induced marker expression. Allogeneic mixed leukocyte reaction showed that the cytokines promoted T-cell proliferation and revealed a potential to boost both Th1 and Th2 polarizing cytokines. GM-CSF and Flt3-L and their combination improved the capability of cDC1 for dextran uptake, while in cDC2, dextran capture was improved by GM-CSF. The data suggest that GM-CSF, IL-4 and Flt3-L and combinations might be beneficial for DC viability and function <jats:italic>in vitro<\/jats:italic>. Limited viability of cDCs could be a confounding variable experimentally and in immunotherapy.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1058963","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T06:41:16Z","timestamp":1673592076000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["GM-CSF, Flt3-L and IL-4 affect viability and function of conventional dendritic cell types 1 and 2"],"prefix":"10.3389","volume":"13","author":[{"given":"Seyed Mohammad","family":"Lellahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waqas","family":"Azeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Paulsen Rye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kon","family":"Reikvam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Henning","family":"Kalland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-015-2005-0","article-title":"Human dendritic cell subsets and function in health and disease","volume":"72","author":"O\u2019Keeffe","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/imm.12888","article-title":"Human dendritic cell subsets: An update","volume":"154","author":"Collin","year":"2018","journal-title":"Immunology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00675-7","article-title":"Expanding dendritic cell nomenclature in the single-cell era","volume":"22","author":"Ginhoux","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1051\/medsci\/20153108008","article-title":"Origine et d\u00e9veloppement des cellules dendritiques humaines","volume":"31","author":"Breton","year":"2015","journal-title":"m\u00e9decine\/sciences"},{"key":"B5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s40425-019-0580-6","article-title":"The clinical application of cancer immunotherapy based on naturally circulating dendritic cells","volume":"7","author":"Bol","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.4.1109","article-title":"Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte\/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha","volume":"179","author":"Sallusto","year":"1994","journal-title":"J Exp Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1084\/jem.176.6.1693","article-title":"Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor","volume":"176","author":"Inaba","year":"1992","journal-title":"J Exp Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.trsl.2015.07.008","article-title":"Antitumor dendritic cell\u2013based vaccines: lessons from 20 years of clinical trials and future perspectives","volume":"168","author":"Constantino","year":"2016","journal-title":"Transl Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12967-018-1507-6","article-title":"First results on survival from a large phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma","volume":"16","author":"Liau","year":"2018","journal-title":"J Transl Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdj138","article-title":"Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG","volume":"17","author":"Schadendorf","year":"2006","journal-title":"Ann Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2096363","DOI":"10.1080\/2162402X.2022.2096363","article-title":"Trial watch: Dendritic cell (DC)-based immunotherapy for cancer","volume":"11","author":"Laureano","year":"2022","journal-title":"Oncoimmunology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: Update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1189\/jlb.0912452","article-title":"Human blood mDC subsets exhibit distinct TLR repertoire and responsiveness","volume":"93","author":"H\u00e9mont","year":"2013","journal-title":"J Leukoc. Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2006.12.020","article-title":"Regulation of the lifespan in dendritic cell subsets","volume":"44","author":"Chen","year":"2007","journal-title":"Mol Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.5.1734.h81702001734_1734_1741","article-title":"Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs","volume":"100","author":"Kamath","year":"2002","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/ni1462","article-title":"Origin of dendritic cells in peripheral lymphoid organs of mice","volume":"8","author":"Liu","year":"2007","journal-title":"Nat Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.9.4910","article-title":"Anatomical origin of dendritic cells determines their life span in peripheral lymph nodes","volume":"165","author":"Ruedl","year":"2000","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cytogfr.2007.10.004","article-title":"Dendritic cells and cytokines in human inflammatory and autoimmune diseases","volume":"19","author":"Blanco","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.119741","article-title":"Increase of dendritic cells of type 2 (DC2) by altered response to IL-4 in atopic patients","volume":"108","author":"Uchida","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2014.07.011","article-title":"Maintaining dendritic cell viability in culture","volume":"63","author":"Vremec","year":"2015","journal-title":"Mol Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1600-065X.2010.00916.x","article-title":"Programmed cell death of dendritic cells in immune regulation","volume":"236","author":"Chen","year":"2010","journal-title":"Immunol Rev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302929","article-title":"Dendritic cell maturation and survival are differentially regulated by TNFR1 and TNFR2","volume":"193","author":"Maney","year":"2014","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.00222","article-title":"Expression of the phosphatase Ppef2 controls survival and function of CD8+ dendritic cells","volume":"10","author":"Zwick","year":"2019","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90010-V","article-title":"A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations","volume":"65","author":"Matthews","year":"1991","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1615","article-title":"The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues","volume":"9","author":"Waskow","year":"2008","journal-title":"Nat Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4081\/oncol.2012.e8","article-title":"An overview on the role of FLT3-tyrosine kinase receptor in acute myeloid leukemia: biology and treatment","volume":"6","author":"Grafone","year":"2012","journal-title":"Oncol Rev"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1084\/jem.175.5.1157","article-title":"Identification of proliferating dendritic cell precursors in mouse blood","volume":"175","author":"Inaba","year":"1992","journal-title":"J Exp Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2478(92)90145-E","article-title":"Development of a langerhans cell phenotype from peripheral blood monocytes","volume":"31","author":"Rossi","year":"1992","journal-title":"Immunol Lett"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.05.018","article-title":"GM-CSF mouse bone marrow cultures comprise a heterogeneous population of CD11c+MHCII+ macrophages and dendritic cells","volume":"42","author":"Helft","year":"2015","journal-title":"Immunity"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpz1.410","article-title":"The In vitro differentiation of human CD141+CLEC9A+ dendritic cells from mobilized peripheral blood CD34+ hematopoietic stem cells","volume":"2","author":"Swartz","year":"2022","journal-title":"Curr Protoc"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1039\/C9RA00818G","article-title":"Properties of immature and mature dendritic cells: phenotype, morphology, phagocytosis, and migration","volume":"9","author":"Kim","year":"2019","journal-title":"RSC Adv"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.3390\/cancers13071525","article-title":"The Flt3L\/Flt3 axis in dendritic cell biology and cancer immunotherapy","volume":"13","author":"Cueto","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00438","article-title":"Dual pro- and anti-inflammatory features of monocyte-derived dendritic cells","volume":"11","author":"Azeem","year":"2020","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1146\/annurev.immunol.22.012703.104538","article-title":"Cell biology of antigen processing in vitro and in vivo","volume":"23","author":"Trombetta","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0910609107","article-title":"Mature dendritic cells use endocytic receptors to capture and present antigens","volume":"107","author":"Platt","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000642","article-title":"Dendritic cells continue to capture and present antigens after maturation In vivo","volume":"185","author":"Drutman","year":"2010","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy","volume":"12","author":"Palucka","year":"2012","journal-title":"via dendritic Cells Nat Rev Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3390\/vaccines10070999","article-title":"Stability program in dendritic cell vaccines: A \u201cReal-world\u201d experience in the immuno-gene therapy factory of romagna cancer center","volume":"10","author":"Pancisi","year":"2022","journal-title":"Vaccines"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1417620112","article-title":"Prosurvival bcl-2 family members reveal a distinct apoptotic identity between conventional and plasmacytoid dendritic cells","volume":"112","author":"Carrington","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830250722","article-title":"Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-\u03b1, but strongly enhanced by interleukin-10","volume":"25","author":"Ludewig","year":"1995","journal-title":"Eur J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"25060","DOI":"10.1038\/srep25060","article-title":"Plasmacytoid dendritic cells are short-lived: reappraising the influence of migration, genetic factors and activation on estimation of lifespan","volume":"6","author":"Zhan","year":"2016","journal-title":"Sci Rep"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2006.001757.x","article-title":"Culture medium and protein supplementation in the generation and maturation of dendritic cells","volume":"63","author":"Royer","year":"2006","journal-title":"Scand J Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1590\/0001-3765201920190310","article-title":"In vitro generation of human monocyte-derived dendritic cells methodological aspects in a comprehensive review","volume":"91","author":"Cechim","year":"2019","journal-title":"An. Acad Bras Cienc"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000474","article-title":"Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103 + conventional dendritic cells","volume":"8","author":"Zhou","year":"2020","journal-title":"J Immunother. Cancer"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cti2.1141","article-title":"Human CLEC9A antibodies deliver wilms\u2019 tumor 1 (WT1) antigen to CD141 + dendritic cells to activate na\u00efve and memory WT1-specific CD8 + T cells","volume":"9","author":"Pearson","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01267","article-title":"The superior ability of human BDCA3+ (CD141+) dendritic cells (DCs) to cross-present antigens derived from necrotic lung cancer cells","volume":"11","author":"Gu","year":"2020","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20092140","article-title":"Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens","volume":"207","author":"Jongbloed","year":"2010","journal-title":"J Exp Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.00971","article-title":"Human blood CD1c+ dendritic cells promote Th1 and Th17 effector function in memory CD4+ T cells","volume":"8","author":"Leal Rojas","year":"2017","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-038422","article-title":"Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets","volume":"109","author":"Piccioli","year":"2007","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-495424","article-title":"Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses","volume":"122","author":"Nizzoli","year":"2013","journal-title":"Blood"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-206318","article-title":"The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis","volume":"114","author":"Kingston","year":"2009","journal-title":"Blood"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2467","article-title":"Re(de)fining the dendritic cell lineage","volume":"13","author":"Satpathy","year":"2012","journal-title":"Nat Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.0105-2896.2009.00888.x","article-title":"Features of the dendritic cell lineage","volume":"234","author":"Steinman","year":"2010","journal-title":"Immunol Rev"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.11.3489","article-title":"Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells","volume":"95","author":"McKenna","year":"2000","journal-title":"Blood"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506088102","article-title":"Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease","volume":"102","author":"Whartenby","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030323","article-title":"Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells In vivo","volume":"198","author":"Karsunky","year":"2003","journal-title":"J Exp Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-370130","article-title":"Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy","volume":"119","author":"van de Laar","year":"2012","journal-title":"Blood"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2007.09.001","article-title":"Factors influencing the generation of murine dendritic cells from bone marrow: The special role of fetal calf serum","volume":"212","author":"Lutz","year":"2008","journal-title":"Immunobiology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2008.08.006","article-title":"Accelerated differentiation of bone marrow-derived dendritic cells in atopic prone mice","volume":"8","author":"Koike","year":"2008","journal-title":"Int Immunopharmacol."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.12.6762","article-title":"The development, maturation, and turnover rate of mouse spleen dendritic cell populations","volume":"165","author":"Kamath","year":"2000","journal-title":"J Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.dci.2003.09.010","article-title":"Regulation of myeloid development and function by colony stimulating factors","volume":"28","author":"Barreda","year":"2004","journal-title":"Dev Comp Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002683","article-title":"The acquisition of antigen cross-presentation function by newly formed dendritic cells","volume":"186","author":"Sathe","year":"2011","journal-title":"J Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020045","article-title":"The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte\/macrophage colony-stimulating factor","volume":"195","author":"Gilliet","year":"2002","journal-title":"J Exp Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-056424","article-title":"Deficiency of bim in dendritic cells contributes to overactivation of lymphocytes and autoimmunity","volume":"109","author":"Chen","year":"2007","journal-title":"Blood"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01009-w","article-title":"Repositioning TH cell polarization from single cytokines to complex help","volume":"22","author":"Tuzlak","year":"2021","journal-title":"Nat Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13024-018-0255-7","article-title":"Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of parkinson\u2019s disease","volume":"13","author":"Schutt","year":"2018","journal-title":"Mol Neurodegener."},{"key":"B68","doi-asserted-by":"publisher","first-page":"101518","DOI":"10.1016\/j.smim.2021.101518","article-title":"GM-CSF: Master regulator of the T cell-phagocyte interface during inflammation","volume":"54","author":"Ingelfinger","year":"2021","journal-title":"Semin Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.02679","article-title":"The pleiotropic effects of the GM-CSF rheostat on myeloid cell differentiation and function: More than a numbers game","volume":"10","author":"Zhan","year":"2019","journal-title":"Front Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1016\/j.jaci.2020.12.638","article-title":"GM-CSF instigates a dendritic cell\u2013t-cell inflammatory circuit that drives chronic asthma development","volume":"147","author":"Nobs","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20131397","article-title":"Classical Flt3L-dependent dendritic cells control immunity to protein vaccine","volume":"211","author":"Anandasabapathy","year":"2014","journal-title":"J Exp Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202149663","article-title":"Flt3L, LIF, and IL-10 combination promotes the selective in vitro development of ESAM low cDC2B from murine bone marrow","volume":"52","author":"Cyran","year":"2022","journal-title":"Eur J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1058963\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T06:41:20Z","timestamp":1673592080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1058963\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":72,"alternative-id":["10.3389\/fimmu.2022.1058963"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1058963","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]},"article-number":"1058963"}}